Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(34 sites)

United States

National Jewish Health, Denver, Colorado

Mayo Clinic, Rochester, Minnesota

Cleveland Clinic, Cleveland, Ohio

The Ohio State University Wexner Medical Center, Columbus, Ohio

University of Pennsylvania, Philadelphia, Pennsylvania

Medical University of South Carolina, Charleston, South Carolina

Vanderbilt University Medical Center, Nashville, Tennessee

Canada

University of Alberta, Edmonton, Alberta

St Joseph's Healthcare Hamilton, Hamilton, Ontario

University of Toronto, Toronto, Ontario

France

CHU Nice, Nice

Hopital Cochin, Paris

Chu Rangueil, Toulouse

Germany

Medius Kliniken gGmbh, Kirchheim unter Teck, Studienzentrale

Italy

Istituto Auxologico Italiano IRCCS, Milan

Fondazione Policlinico Universitario Campus Bio-Medico, Roma

Azienda Provinciale per i Servizi Sanitari Provincia Autonoma Trento, Trento

Azienda Ospedaliera Universitaria Integrata Verona, Verona

Japan

Chiba University Hospital, Chuo-ku, Chiba-shi, Chiba

Hospital of the University of Occupational and Environmental Health, Japan, Kitakyushu, Fukuoka

Hokkaido University Hospital, Sapporo, Hokkaido

NHO Sagamihara National Hospital, Sagamihara, Kanagawa

National Hospital Organization Yokohama Medical Center, Yokohama, Kanagawa

Tohoku University Hospital, Sendai, Miyagi

Osaka Habikino Medical Center, Habikino, Osaka

Saitama Medical Center, Kawagoe, Saitama

Juntendo University Hospital, Bunkyo-ku, Tokyo

Kyorin University Hospital, Mitaka, Tokyo

Toho University Omori Medical Center, Ōta-ku, Tokyo

Spain

Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, A Coruna

Complejo Hospitalario de Navarra, Pamplona

United Kingdom

Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham

Addenbrookes Hospital, Cambridge

Royal Berkshire NHS Foundation Trust, Reading